QualityDipStocks / Industrials · Major Chemicals
Huntsman HUN
Outside our quality screen, so we don’t track its dips. It’s 37% below its 52-week high.
Outside our quality screen, trading below our fair value estimate, 7% over its Market Value.
- Fair value est.
- $12.37+24%
- Market Value
- $9.29price +7%
- Off 52-wk high
- −37%
- Risk vs market
- Market-likebeta 0.90
52-week range 30% of the way from its 52-week low to its high
Price $9.95Fair value est. $12.37Market Value $9.29
4 bullish · 5 bearish See why
Repriced or dip?
Dip: business intact
The price is 37% below its 52-week high (Jun 15), but the business held up: revenue +8.1%, revenue growth rate +11.2 pts, operating margin +3.3 pts.
Some numbers held up (revenue +8.1%, revenue growth rate +11.2 pts, operating margin +3.3 pts), others slipped (free cash flow $135M → −$85M, turned negative). The price is 37% below its 52-week high.
The price is 37% below its 52-week high, and the business changed too: free cash flow $135M → −$85M, turned negative.
Within 10% of its 52-week high, so there is no dip to judge yet.
The evidence 8 numbers, high vs now
- Revenue, last 12 months$5.7B → $6.2B (+8.1%)held up
- Revenue growth rate−4.7% → +6.5% a year (+11.2 pts)held up
- Free cash flow, 12 months$135M → −$85M, turned negativechanged
- Operating margin−3.3% → 0.0% (+3.3 pts)held up
- Shares outstanding0.0% (unchanged)held up
- Net cash (cash minus debt)+0.2% of market cap since the highheld up
- Stock vs its sector (Industrials)stock −37%, sector median −8% since Jun 15changed
- Price fall vs business numbersprice −37%, revenue/EPS/FCF median +8% (shown, not scored)
Business numbers as reported at the high (12 months to Mar 31, 2026) vs the latest filing (12 months to Sep 30, 2026). Each measure is scored from −1 (business changed) to +1 (business intact) and weighted: revenue, earnings per share, free cash flow, operating margin, revenue growth rate, share count, net cash and the move vs its sector. 60 or more reads as a dip, 40 or less as a repricing. Analyst estimates are not in our data, so they are not used. How to read it
Data-based read, not advice.
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
How the range is computed
Ten-year free-cash-flow DCF. Same 10-year free-cash-flow model as the base: discount rate 9.5% ±1 point and growth 3.0% ±2 points. Bear = 10.5% and 1.0%; bull = 8.5% and 5.0% (both fade to 3%). A model estimate from public filings, not a forecast of where the price will go.
Price sits inside the range.
What the price implies To be worth today’s price, HUN’s free cash flow would need to shrink about 1% a year for five years; our estimate uses 3%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much HUN moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Moves about in line with the market, and its own price swings are 4.7× the S&P 500’s.
- Beta vs S&P 500
- 0.90
- Volatility
- 60% vs 13% SPY
- Correlation SPY
- 0.19
- Correlation QQQ
- 0.14
How it ranks
Where HUN stands vs every one of the 2,467 stocks we cover that has the number. Longer bar = better.
Not in the top quarter on any of these 6 measures
- Discount to fair value estimate24% · price below our base caseTop 32%of 1,507
- Free cash flow yield−4.9% · free cash flow vs market capLowest 9%of 1,690
- Dividends + buybacks yield3.6% · cash paid out or used to retire shares, vs market capTop 38%of 2,227
- Revenue growth, last 12 months+6.5% · vs the 12 months beforeLowest 37%of 2,184
- Operating margin0% · of sales kept as operating profitLowest 15%of 1,549
- Return on invested capital0% · profit per dollar of capitalLowest 11%of 1,001
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
DCF $12.37 · MV $9.29 · FCF value $21.95
Assumes 3.0% growth for 5 years (revenue grew -10.9% a year FY22–FY25; floored at 3%), fading to 3%; 9.5% discount rate, 3% terminal growth. FCF base $0.78 a share (trailing 12 months to Mar 31, 2026), from the 10-Q filed May 1, 2026. Net debt $1.7B, not deducted.
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 4 of 5
ValuationOur DCF fair value estimate is $12.37, 24% above the price.
Cash returnsDividend yield of 3.6% ($62M paid over 12 months).
ValuationPrice / book of 0.6×, below the 3.3× median for the 274 Industrials companies we cover.
ValuationEV/EBITDA of 11.3×, below the 14.8× median for the 180 Industrials companies we cover.
Top bearish points 5 of 5
ProfitabilityLost $173M over the last 12 months (net income, SEC filings).
Cash returnsFree cash flow was negative over the last 12 months (−$85M).
Balance sheetNet debt of $1.7B, 98% of the market cap (Sep 30, 2026).
GrowthSales shrank 11% a year from FY2022 to FY2025.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%; net debt 7.7× EBITDA (limit 3×).
All fundamentals
FCF yield -4.9% · ROE -6% · Sales +6%
Valuation
- P/E
- n/aloss over the last 12 months
- Price / FCF
- n/anegative free cash flow
- FCF yield
- −4.9%
- EV / EBITDA
- 11.3×
- Price / sales
- 0.28×
- Price / book
- 0.65×
- Market cap
- $1.7Bprice × diluted shares
- Enterprise value
- $3.4B
Growth
- Revenue, 12 months
- $6.2B
- Sales growth, 12 months
- +6.5%vs the 12 months before
- Sales growth, 3 yrs
- −10.9%/yrfrom FY2022
- Diluted EPS, 12 months
- −$1.00
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- −$173M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- 13.5%
- Operating margin
- 0.0%
- Net margin
- −2.8%
- FCF margin
- −1.4%
- Return on equity
- −6%
- Return on invested capital
- 0%
Balance sheet
- Cash & short-term inv.
- $359M
- Total debt
- $2.0B
- Net cash
- −$1.7B
- Debt / equity
- 0.77×
- Interest coverage
- n/ainterest expense not tagged in SEC data
Cash flow & returns
- Free cash flow, 12 months
- −$85M
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 3.60%$62M paid
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +0.5%diluted shares vs a year ago
- Stock-based comp
- $31M
Trailing 12 months to Sep 30, 2026; balance sheet at Sep 30, 2026. From Huntsman’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.1B · Sales +14%
- Free cash flow, 12 months$0.1B
- Free-cash-flow yield-4.9%
- Free-cash-flow margin3%
- Gross margin14%
- Operating margin2%
- Return on invested capital2%
- Return on equity−4%
- Sales growth (latest quarter vs year-ago quarter)+14%
- Net debt / EBITDA7.7×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $9.95
- 52-wk lowlowest close, 1 year$7.42−25.4%
- Market Valueavg paid since Jul 30$9.29−6.6%
- PriceMon Nov 2 close$9.95you are here
- Fair value est.base case$12.37+24.3%
- 52-wk highhighest close, 1 year$15.89+59.7%
Momentum & 52-week range
RSI 70 · 5 days +11.9%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
HUN is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Huntsman in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 5:14 PM ET.
Compare with peers
Closest in size in Major Chemicals
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.